Blogs & Forums

Updated: October 2, 2020

Informal Information Sources to Help You Stay Current 

In this section we have gathered some of the most popular peer-to-peer information sources, such as blogs, discussion forums and other social media resources. Industry information is always changing - for the latest news, current issues and popular opinions - try following one or more of these sources. In addition, blogs and forums usually give you the opportunity to join the conversation, either by posting comments, questions or opinions of your own. 

High Technology Blogs & Podcasts:

 

TradeSecrets - a blog from Nature Biotechnology
A blog from the Nature Biotechnology journal, which is a monthly journal covering the science and business of biotechnology.

Start here: Startup Lessons from a Researcher

Startup Lessons Learned
Written by Eric Ries, 2009 recipient of the TechFellow award and 2010 Harvard Business School Entrepreneur-in-Residence, this blog provides a range of insights for the prospective startup, including literature highlights and business trend analysis.

Start here: The Founder's Dilemmas: Equity Splits

Tech Crunch
TechCrunch is a group edited blog dedicated to profiling startups, particularly in the web 2.0 sector, as well as, reviewing new internet products, and breaking tech news.

Start here: Crowdfunding: $1.5B Raised, 1M Campaigns Funded In 2011; Figures Set To Double In 2012

Women2.0
Women2.0 aims to increase the number of female founders of technology startups. Women 2.0 enables entrepreneurs with the network, resources and knowledge to take your startup from idea to launch.

Start here: Founder Friday Silicon Valley Hosted By Two Female Engineers Who Became VC-Funded Startup Founders

The Tech Entrepreneur Podcast
A selection of downloadable podcasts discussing strategies and issues facing high technology startups.

 Start here: Partnering and Funding for the Startup

 

High Technology Discussion Forums

 

Nature Biotechnology Bioentrepreneur Forum
A forum for discussing the intersection between bench research and the commercial side of the biotechnology industry.